+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Trials Market Research Report by Design (Observational Study and Treatment Study), by Phase (Phase I, Phase II, Phase III, and Phase IV), by Indication - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5134269
  • Report
  • July 2020
  • Region: Global
  • 206 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Clinical Trials Market to Grow USD 68,854.13 Million by 2025, at a CAGR of 8.60%

FEATURED COMPANIES

  • Charles River Laboratory
  • Clinipace
  • Eli Lilly and Company
  • ICON PLC
  • IQVIA
  • Novo Nordisk A/S
  • MORE
The Global Clinical Trials Market is expected to grow from USD 41,963.49 Million in 2019 to USD 68,854.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.60%.

Market Segmentation & Coverage:

This research report categorizes the Clinical Trials to forecast the revenues and analyze the trends in each of the following sub-markets:

The Treatment Study is projected to witness the highest growth during the forecast period

Based on Design, the Clinical Trials Market studied across Observational Study and Treatment Study. The Observational Study further studied across Case Control Study, Cohort Study, Cross Sectional Study, and Ecological Study. The Treatment Study further studied across Adaptive Clinical Trial, Non-randomized Control Trial, and Randomized Control Trial. The Observational Study commanded the largest size in the Clinical Trials Market in 2019. On the other hand, the Treatment Study is expected to grow at the fastest CAGR during the forecast period.

The Phase II is projected to witness the highest growth during the forecast period

Based on Phase, the Clinical Trials Market studied across Phase I, Phase II, Phase III, and Phase IV. The Phase III commanded the largest size in the Clinical Trials Market in 2019. On the other hand, the Phase II is expected to grow at the fastest CAGR during the forecast period.

The Oncology is projected to witness the highest growth during the forecast period

Based on Indication, the Clinical Trials Market studied across Autoimmune/Inflammation, CNS condition, Cardiovascular, Diabetes, Obesity, Oncology, and Pain management. The Autoimmune/Inflammation commanded the largest size in the Clinical Trials Market in 2019. On the other hand, the Oncology is expected to grow at the fastest CAGR during the forecast period.

Based on Geography, the Clinical Trials Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trials Market including Charles River Laboratory, Chiltern International Ltd., Clinipace, Eli Lilly and Company, ICON PLC, IQVIA, Novo Nordisk A/S, PAREXEL International Corporation, Pfizer Inc., Pharmaceutical Product Development, LLC, PRA Health Sciences, SGS SA, Syneos Health, and Wuxi AppTec Inc..

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trials Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Trials Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Trials Market?
6. What are the modes and strategic moves considered suitable for entering the Global Clinical Trials Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Charles River Laboratory
  • Clinipace
  • Eli Lilly and Company
  • ICON PLC
  • IQVIA
  • Novo Nordisk A/S
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Design Outlook
3.3. Phase Outlook
3.4. Indication Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Rising prevalence of diseases
5.2.2. Shift towards patient centric clinical trials
5.2.3. Improved clinical trails due to CRO consolidation
5.3. Restraints
5.3.1. Dearth of skilled clinical research professional
5.3.2. Rising cost of clinical trials
5.4. Opportunities
5.4.1. Demand for clinical trials in the emerging economies
5.4.2. High R&D expenditure by the pharmaceutical industry
5.5. Challenges
5.5.1. Stringent regulations for patient enrollment

6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations

7. Global Clinical Trials Market, By Design
7.1. Introduction
7.2. Observational Study
7.2.1. Case Control Study
7.2.2. Cohort Study
7.2.3. Cross Sectional Study
7.2.4. Ecological Study
7.3. Treatment Study
7.3.1. Adaptive Clinical Trial
7.3.2. Non-randomized Control Trial
7.3.3. Randomized Control Trial

8. Global Clinical Trials Market, By Phase
8.1. Introduction
8.2. Phase I
8.3. Phase II
8.4. Phase III
8.5. Phase IV

9. Global Clinical Trials Market, By Indication
9.1. Introduction
9.2. Autoimmune/Inflammation
9.3. CNS condition
9.4. Cardiovascular
9.5. Diabetes
9.6. Obesity
9.7. Oncology
9.8. Pain management

10. Global Clinical Trials Market, By Geography
10.1. Introduction
10.2. Americas
10.2.1. Argentina
10.2.2. Brazil
10.2.3. Canada
10.2.4. Mexico
10.2.5. United States
10.3. Asia-Pacific
10.3.1. Australia
10.3.2. China
10.3.3. India
10.3.4. Indonesia
10.3.5. Japan
10.3.6. Malaysia
10.3.7. Philippines
10.3.8. South Korea
10.3.9. Thailand
10.4. Europe, Middle East & Africa
10.4.1. France
10.4.2. Germany
10.4.3. Italy
10.4.4. Netherlands
10.4.5. Qatar
10.4.6. Russia
10.4.7. Saudi Arabia
10.4.8. South Africa
10.4.9. Spain
10.4.10. United Arab Emirates
10.4.11. United Kingdom

11. Competitive Strategic Window
11.1. Introduction
11.2. Competitive Strategic Window, by Design
11.3. Competitive Strategic Window, by Phase
11.4. Competitive Strategic Window, by Indication
11.5. Competitive Strategic Window, by Geography

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Charles River Laboratory
13.2. Chiltern International Ltd.
13.3. Clinipace
13.4. Eli Lilly and Company
13.5. ICON PLC
13.6. IQVIA
13.7. Novo Nordisk A/S
13.8. PAREXEL International Corporation
13.9. Pfizer Inc.
13.10. Pharmaceutical Product Development, LLC
13.11. PRA Health Sciences
13.12. SGS SA
13.13. Syneos Health
13.14. Wuxi AppTec Inc.

14. Appendix
14.1. Discussion Guide
14.2. Edition Details
14.3. License Details
14.4. Pricing Details

LIST OF FIGURES
FIGURE 1. GLOBAL CLINICAL TRIALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CLINICAL TRIALS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL CLINICAL TRIALS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2019 VS 2025 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2019 VS 2025 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 8. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIALS MARKET, BY TYPE
FIGURE 9. GLOBAL CLINICAL TRIALS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL TRIALS MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIALS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL CLINICAL TRIALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2019 VS 2025 (USD MILLION)
FIGURE 14. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2019 VS 2025 (USD MILLION)
FIGURE 15. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 17. AMERICAS CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2025
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2025
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 24. GLOBAL CLINICAL TRIALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 25. GLOBAL CLINICAL TRIALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. GLOBAL CLINICAL TRIALS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 3. GLOBAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CASE CONTROL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIALS MARKET SIZE, BY COHORT STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CROSS SECTIONAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ECOLOGICAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIALS MARKET SIZE, BY TREATMENT STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ADAPTIVE CLINICAL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIALS MARKET SIZE, BY NON-RANDOMIZED CONTROL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIALS MARKET SIZE, BY RANDOMIZED CONTROL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIALS MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CNS CONDITION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIALS MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 26. AMERICAS CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 27. AMERICAS CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 28. AMERICAS CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 29. AMERICAS CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 30. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 31. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 32. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 33. BRAZIL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 34. BRAZIL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 35. BRAZIL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 36. CANADA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 37. CANADA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 38. CANADA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 39. MEXICO CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 40. MEXICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 41. MEXICO CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 42. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 43. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 44. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 45. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 46. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 47. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 48. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 49. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 50. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 51. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 52. CHINA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 53. CHINA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 54. CHINA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 55. INDIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 56. INDIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 57. INDIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 58. INDONESIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 59. INDONESIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 60. INDONESIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 61. JAPAN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 62. JAPAN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 63. JAPAN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 64. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 65. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 66. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 67. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 68. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 69. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 70. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 71. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 72. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 73. THAILAND CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 74. THAILAND CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 75. THAILAND CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 80. FRANCE CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 81. FRANCE CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 82. FRANCE CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 83. GERMANY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 84. GERMANY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 85. GERMANY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 86. ITALY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 87. ITALY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 88. ITALY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 89. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 90. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 91. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 92. QATAR CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 93. QATAR CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 94. QATAR CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 95. RUSSIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 96. RUSSIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 97. RUSSIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 98. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 99. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 100. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 101. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 102. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 103. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 104. SPAIN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 105. SPAIN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 106. SPAIN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 107. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 110. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
TABLE 111. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
TABLE 112. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
TABLE 113. GLOBAL CLINICAL TRIALS MARKET: SCORES
TABLE 114. GLOBAL CLINICAL TRIALS MARKET: BUSINESS STRATEGY
TABLE 115. GLOBAL CLINICAL TRIALS MARKET: PRODUCT SATISFACTION
TABLE 116. GLOBAL CLINICAL TRIALS MARKET: RANKING
TABLE 117. GLOBAL CLINICAL TRIALS MARKET: MERGER & ACQUISITION
TABLE 118. GLOBAL CLINICAL TRIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 119. GLOBAL CLINICAL TRIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 120. GLOBAL CLINICAL TRIALS MARKET: INVESTMENT & FUNDING
TABLE 121. GLOBAL CLINICAL TRIALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 122. GLOBAL CLINICAL TRIALS MARKET: EDITION DETAILS
TABLE 123. GLOBAL CLINICAL TRIALS MARKET: LICENSE DETAILS
TABLE 124. GLOBAL CLINICAL TRIALS MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
3 of 3
  • Charles River Laboratory
  • Chiltern International Ltd.
  • Clinipace
  • Eli Lilly and Company
  • ICON PLC
  • IQVIA
  • Novo Nordisk A/S
  • PAREXEL International Corporation
  • Pfizer Inc.
  • Pharmaceutical Product Development, LLC
  • PRA Health Sciences
  • SGS SA
  • Syneos Health
  • Wuxi AppTec Inc.
Note: Product cover images may vary from those shown
Adroll
adroll